5Hani N. Sabbah Ph.D.,William C. Stanley Ph.D.. Metabolic Therapy for Heart Disease: Impact of Trimetazidine[J] 2005,Heart Failure Reviews(4):281～288
二级参考文献22
1Wasserman K.Dyspnea on exertion[J].JAMA,1982,248(9):2039-2044.
2Rogers FJ. The muscle hypothesis: a model of chronic heart failure appropriate for osteopathic medicine[J].J Am Osteopath Assoc,2001,101 ( 10):576-583.
3Packer M, Cohn JN.Consensus recommendations for the management of chronic heart failure[J].Am J Cardiol,1999,83:1A-38A.
4Belardineui R,Georgion D,Scocco V,et al.Low intensity exercise training in patients with chronic heart failure [J].J Am Coll Cardiol, 1995,26:975-982.
5Bitter V, Weiner DH,Yusuf S,et al.Predietion of mortality and morbidity with a 6-minute walk test in patients with left ventrieular dysfunction [ J ].JAMA,1993,270(15):1702-1707.
6Rector TS,Cohn JN.With the Pimobendan Muhicenter Research Group Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire:reliability and validity during a randomized,double-blind,placebo-controlled trial of pimobendan[J].Am Heart J,1992,102(4):1017-1025.
8Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation, 2002,105:1387-1393.
9European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J, 1998, 19:990-1003.
10Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation, 2000,101:2118-2121.
